
Analyse af perspektiver og vækstbarrierer for udvikling af dansk biotek 27 March 2017
Analyse af perspektiver og vækstbarrierer for udvikling af dansk biotek IRIS Group har netop publiceret... Read more

Analyse af perspektiver og vækstbarrierer for udvikling af dansk biotek IRIS Group har netop publiceret... Read more

Y-mAbs Therapeutics, Inc. receives first European Orphan Drug Designation NEW YORK, March 1, 2017 –... Read more

Indstillingsskema Novo Nordisk Fondens Gymnasielærerpris 2017 Opslag Novo Nordisk Fondens Gymnasielærerpris... Read more
7 principper for sundhedsdata >>

Biogen will pay Forward a non-refundable cash fee of $1.25 billion Forward may be eligible to receive... Read more

Y-mAbs Therapeutics, Inc. closes $12 million in private placement among current shareholders NEW YORK,... Read more

Det danske biotekselskab Minervax melder om positive resultater fra et fase 1-forsøg med dets vaccine... Read more

IO Biotech develops novel therapeutic immuno-oncology vaccines targeting immune check point inhibitory... Read more

Join us in New York to meet with top investors, pharma & partners hosted at Citi Headquarters. -Special... Read more